Advent Capital Management HALOZYME THERAPEUTICS IN Transaction History

Advent Capital Management

11,220,000

Previous 41,231,000 72.79%

Previous $0 NaN%

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	N/A	-30,011,000 Reduced 72.79%	11,220,000 $0
Q4 2024 Feb 13, 2025	BUY	N/A	41,116,000 Added 35753.04%	41,231,000 $0
Q3 2024 Nov 13, 2024	SELL	N/A	-22,918,000 Reduced 99.5%	115,000 $0
Q2 2024 Aug 13, 2024	SELL	N/A	-26,894,000 Reduced 53.87%	23,033,000 $0
Q1 2024 May 14, 2024	SELL	N/A	-6,066,000 Reduced 10.83%	49,927,000 $0
Q4 2023 Feb 13, 2024	SELL	N/A	-18,360,000 Reduced 24.69%	55,993,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	74,353,000 New	74,353,000 $0

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.